LabID-base/OpenAlex-Afillation huggingface dataset:
EPH109 Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review
Year: 2025
Type: article
Language: en
Topic: Vaccine Coverage and Hesitancy
Authors and affiliations:
raw_author_name: Yoanna Todorova
raw_affiliation_strings: King's College London, London, United Kingdom
raw_author_name: Kate Cullen
raw_affiliation_strings: Red Nucleus, London, United Kingdom
raw_author_name: Mitun Patel
raw_affiliation_strings: Red Nucleus, London, United Kingdom
CO53 Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study
Year: 2025
Type: article
Language: en
Topic: Lung Cancer Treatments and Mutations
Authors and affiliations:
raw_author_name: Rahul Mudumba
raw_affiliation_strings: PhD Candidate, University of Southern California, Los Angeles, CA, USA
raw_author_name: Xiaofan Liu
raw_affiliation_strings: University of Southern California, Los Angeles, CA, USA
raw_author_name: Jorge J. Nieva
raw_affiliation_strings: University of Southern California, Los Angeles, CA, USA
raw_author_name: John Romley
raw_affiliation_strings: University of Southern California, Los Angeles, CA, USA
PT19 Can Estimands Support Aligned Evidence Generation for EU HTA? Reflections on Their Role in Joint Clinical Assessments, PICO Alignment, and Beyond
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Antonia Morga
raw_affiliation_strings: Head, New Product Planning, Global Value Evidence, Astellas Pharma Ltd, Addlestone, United Kingdom
raw_author_name: Antonio Remiro Azócar
raw_affiliation_strings: Novo Nordisk A/S, Madrid, Spain
raw_author_name: Tatsiana Vaitsiakhovich
raw_affiliation_strings: Sanofi, Berlin, Germany
raw_author_name: Emmanuelle Boutmy
raw_affiliation_strings: Merck KGaA, Darmstadt, Germany
raw_author_name: Frank Kleinjung
raw_affiliation_strings: Sanofi-Aventis Deutschland GmbH, Berlin, Germany
raw_author_name: Lotte Husemoen
raw_affiliation_strings: Novo Nordisk A/S, Bagsværd, Denmark
raw_author_name: barbara rosettani
raw_affiliation_strings: Valos Srl., Porto Sant'Elpidio, Italy
raw_author_name: khadija RERHOU. Rantell
raw_affiliation_strings: MHRA, london, United Kingdom
raw_author_name: Alessandro Ghiretti
raw_affiliation_strings: Daiichi Sankyo, Roma, Italy
raw_author_name: pepa polavieja
raw_affiliation_strings: Novo Nordisk Spain, Pozuelo de Alarcon, Spain
RWD77 Evaluating a Potential Link Between Alprazolam and Intracranial Aneurysm: A Pharmacovigilance and Bioinformatics Approach Through FAERS and Molecular Docking
Year: 2025
Type: article
Language: en
Topic: Pharmacovigilance and Adverse Drug Reactions
Authors and affiliations:
raw_author_name: K.R. SPOORTHI
raw_affiliation_strings: Student, MSRUAS, Mysuru, India
raw_author_name: Eswaran Maheswari
raw_affiliation_strings: Faculty, M S Ramaiah University Of Applied Sciences, Bangalore, India
raw_author_name: A.P. RAVINANDAN
raw_affiliation_strings: Ph.D Scholar, MSRUAS, Bangalore, India
raw_author_name: Sneha Anthony Zalki
raw_affiliation_strings: Student, MSRUAS, Bangalore, India
raw_author_name: J. SHEETAL
raw_affiliation_strings: Student, MSRUAS, Bengalore, India
SA62 Leveraging Real-World Data to Conduct Noninterventional Studies in Rare Disease Populations: Lessons in Scalability and Data Access From Three Observational Studies
Year: 2025
Type: article
Language: en
Topic: Genomics and Rare Diseases
Authors and affiliations:
raw_author_name: Irene Pan
raw_affiliation_strings: United BioSource LLC (UBC), King of Prussia, PA, USA
raw_author_name: Milena Toncheva
raw_affiliation_strings: United BioSource LLC (UBC), Uxbridge, United Kingdom
raw_author_name: Miriana Wennekes
raw_affiliation_strings: United BioSource LLC (UBC), Uxbridge, United Kingdom
HPR231 Unmet Need in IgA Nephropathy (IgAN): Disparity Between Clinical Guidelines and Real-World Practice in Ireland
Year: 2025
Type: article
Language: en
Topic: Renal Diseases and Glomerulopathies
Authors and affiliations:
raw_author_name: Jennifer Leroy
raw_affiliation_strings: Senior Consultant, AXIS - The Reimbursement Experts, Dublin 2, Ireland
raw_author_name: Mohamed Zein
raw_affiliation_strings: AXIS The Reimbursement Experts, Leicester, United Kingdom
raw_author_name: Brenda Dooley
raw_affiliation_strings: AXIS - The Reimbursement Experts, Dublin 2, Ireland
raw_author_name: Antonio Ramirez de Arellano Serna
raw_affiliation_strings: CSL Vifor, Glattbrugg, Switzerland
EE132 Clinical and Economic Perspectives on Influenza and COVID-19 Vaccine Combinations
Year: 2025
Type: article
Language: en
Topic: Influenza Virus Research Studies
Authors and affiliations:
raw_author_name: José BARTELT-HOFER
raw_affiliation_strings: HE&OR, Sanofi, Lyon, France
raw_author_name: Maribel Tribaldos Causadias de Su
raw_affiliation_strings: HE&OR, Sanofi, Lyon, France
CO183 Potential Benefits of Universal Influenza Vaccination on Health Outcomes and Costs in Mexico
Year: 2025
Type: article
Language: en
Topic: Influenza Virus Research Studies
Authors and affiliations:
raw_author_name: Pascal Crépey
raw_affiliation_strings: University of Rennes, Rennes, France
raw_author_name: Diana Vilar
raw_affiliation_strings: Instituto Nacional de Cancerología, México City, Mexico
raw_author_name: Patricia Cervantes
raw_affiliation_strings: Sanofi, México City, Mexico
raw_author_name: José BARTELT-HOFER
raw_affiliation_strings: Sanofi Vaccines, Lyon, France
raw_author_name: Carlos Noda
raw_affiliation_strings: Sanofi, México City, Mexico
RWD82 Expediting Oncology Evidence Generation by Leveraging EMR-Enabled Clinically Rich Real-World Data at Scale
Year: 2025
Type: article
Language: en
Topic: Machine Learning in Healthcare
Authors and affiliations:
raw_author_name: will sopwith
raw_affiliation_strings: IQVIA, Liverpool, United Kingdom
raw_author_name: Marina Borges
raw_affiliation_strings: IQVIA, Portugal
raw_author_name: Oliver Russell
raw_affiliation_strings: IQVIA, London, United Kingdom
raw_author_name: Paula Cardenes
raw_affiliation_strings: IQVIA, BARCELONA, Spain
raw_author_name: Laura Girardat-Rotar
raw_affiliation_strings: IQVIA, Basel, Switzerland
raw_author_name: Benedikt Maissenhaelter
raw_affiliation_strings: IQVIA, Munich, Germany
raw_author_name: Finlay MacDougall
raw_affiliation_strings: IQVIA, London, United Kingdom
EE505 Healthcare Resource Use and Direct Healthcare Costs Associated With Respiratory Syncytial Virus Infections in Individuals Aged 18 Years or Older in Italy: A Retrospective Observational Study
Year: 2025
Type: article
Language: en
Topic: Respiratory viral infections research
Authors and affiliations:
raw_author_name: Anna Puggina
raw_affiliation_strings: GSK, Verona, Italy
raw_author_name: Eleftherios Zarkadoulas
raw_affiliation_strings: GSK, Wavre, Belgium
raw_author_name: Alexander Domnich
raw_affiliation_strings: Hygiene Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, Genoa, Italy
raw_author_name: Chiara Veronesi
raw_affiliation_strings: CliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, Bologna, Italy
raw_author_name: Caterina Rizzo
raw_affiliation_strings: Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
raw_author_name: Marta Vicentini
raw_affiliation_strings: GSK, Verona, Italy
raw_author_name: Luca Degli Esposti
raw_affiliation_strings: CliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, Bologna, Italy
raw_author_name: Giovanna Elisa Calabrò
raw_affiliation_strings: Department of Human Sciences, Society and Health, University of Cassino and Southern Lazio, Cassino, Italy and Value in Health Technology and Academy for Leadership and Innovation (VIHTALI), spin-off of Università Cattolica del Sacro Cuore, Rome, Italy
raw_author_name: Maria João Fonseca
raw_affiliation_strings: GSK, Lisbon, Portugal
CO231 Systematic Review of Prognostic Factors for Efficacy and Safety Outcomes in CAR-T Cell Therapy for Diffuse Large B-cell Lymphoma
Year: 2025
Type: article
Language: en
Topic: CAR-T cell therapy research
Authors and affiliations:
raw_author_name: Jonas Jost
raw_affiliation_strings: MArS Market Access & Pricing Strategy GmbH, Weil am Rhein, Germany
raw_author_name: Jörg Mahlich
raw_affiliation_strings: Miltenyi Biomedicine, Bergisch Gladbach, Germany
raw_author_name: Sybille Riou
raw_affiliation_strings: Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany
raw_author_name: Peter Borchmann
raw_affiliation_strings: Department I of Internal Medicine, Center for Integrated Oncology, Cologne, Germany
raw_author_name: Stefan Walzer
raw_affiliation_strings: MArS Market Access & Pricing Strategy GmbH, Weil am Rhein, Germany
raw_author_name: Jan-Michel Heger
raw_affiliation_strings: UK Koeln, Koeln, Germany
raw_author_name: Julia Schleifenbaum
raw_affiliation_strings: UK Koeln, Koeln, Germany
RWD97 Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Year: 2025
Type: article
Language: en
Topic: Diabetes Treatment and Management
Authors and affiliations:
raw_author_name: Shujiro Takeno
raw_affiliation_strings: IQVIA, Tokyo, Japan
raw_author_name: Rinka Murakami
raw_affiliation_strings: IQVIA Japan, Tokyo, Japan
raw_author_name: Seok-Won Kim
raw_affiliation_strings: IQVIA, Minato, Japan
raw_author_name: Satoshi Murayama
raw_affiliation_strings: IQVIA, Tokyo, Japan
raw_author_name: Minami Yamaguchi
raw_affiliation_strings: IQVIA, Tokyo, Japan
raw_author_name: Tsubasa Shimizu
raw_affiliation_strings: IQVIA, Tokyo, Japan
raw_author_name: Kaneko Shinnosuke
raw_affiliation_strings: IQVIA, Tokyo, Japan
PCR136 Improving the Conceptual Coverage of the 15-item Penn Parkinson’s Daily Activity Questionnaire (PDAQ-15) for Use in the Mild-to-Moderate Lewy Body Dementia Population
Year: 2025
Type: article
Language: en
Topic: Parkinson's Disease Mechanisms and Treatments
Authors and affiliations:
raw_author_name: Daniel Weintraub
raw_affiliation_strings: University of Pennsylvania School of Medicine, Pennsylvania, PA, USA
raw_author_name: JEssica Baldasaro
raw_affiliation_strings: Modus Outcomes, Cary, NC, USA
raw_author_name: Andrew Siderowf
raw_affiliation_strings: University of Pennsylvania School of Medicine, Pennsylvania, PA, USA
raw_author_name: Eugenia Mamikonyan
raw_affiliation_strings: University of Pennsylvania School of Medicine, Pennsylvania, PA, USA
raw_author_name: Antoine Regnault
raw_affiliation_strings: Modus Outcomes, Lyon, France
raw_author_name: Sara Strzok
raw_affiliation_strings: Modus Outcomes, Minneapolis, MN, USA
raw_author_name: Leanne Munsie
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, IN, USA
raw_author_name: Julie Chandler
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, IN, USA
raw_author_name: Kevin Biglan
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, IN, USA
raw_author_name: Laure Delbecque
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, IN, USA
EE727 The Socioeconomic Value of Adult Respiratory Immunization Programs in Spain: How Much Can We Gain From Expanding Prevention Efforts?
Year: 2025
Type: article
Language: en
Topic: Pneumonia and Respiratory Infections
Authors and affiliations:
raw_author_name: Matthew William Napier
raw_affiliation_strings: Office of Health Economics, London, United Kingdom
raw_author_name: Alejandra López-Ibáñez de Aldecoa
raw_affiliation_strings: Pfizer, Madrid, Spain
raw_author_name: Simon Brassel
raw_affiliation_strings: Office of Health Economics, London, United Kingdom
raw_author_name: Yolanda Moreno
raw_affiliation_strings: Pfizer, Madrid, Spain
raw_author_name: Claud Theakston
raw_affiliation_strings: Office of Health Economics, London, United Kingdom
raw_author_name: Francisco Jesus Mesa
raw_affiliation_strings: Pfizer, Madrid, Spain
raw_author_name: Jingyan Yang
raw_affiliation_strings: Pfizer, New York, NY, USA
raw_author_name: Jeffrey Vietri
raw_affiliation_strings: Pfizer, Collegeville, PA, USA
raw_author_name: Diana Mendes
raw_affiliation_strings: Pfizer, Tadworth, United Kingdom
raw_author_name: Tianyan Hu
raw_affiliation_strings: Pfizer, New York, NY, USA
raw_author_name: Lotte Steuten
raw_affiliation_strings: Office of Health Economics, London, United Kingdom
EPH277 Validation Between Antidepressant Treatment Failure Proxy and PHQ-9 Score in Major Depressive Disorder Using a Linked Insurance Claims and Electronic Health Record Dataset
Year: 2025
Type: article
Language: en
Topic: Treatment of Major Depression
Authors and affiliations:
raw_author_name: Rashmi Patel
raw_affiliation_strings: University of Cambridge, Cambridge, United Kingdom
raw_author_name: Carissa White Dukes
raw_affiliation_strings: Boehringer Ingelheim Pharmaceuticals, Inc., Greenwood, IN, USA
raw_author_name: Suzanne St Rose
raw_affiliation_strings: Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
raw_author_name: Anne Kilburg
raw_affiliation_strings: Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
raw_author_name: Sigurd D. Suessmuth
raw_affiliation_strings: Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
raw_author_name: Franco De Crescenzo
raw_affiliation_strings: Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
raw_author_name: Ling Zhang
raw_affiliation_strings: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
EE588 Modeling Framework for Assessing Cost-Effectiveness of New Treatments in Chronic Kidney Disease
Year: 2025
Type: article
Language: en
Topic: Chronic Kidney Disease and Diabetes
Authors and affiliations:
raw_author_name: Junwen Zhou
raw_affiliation_strings: Health Economics Research Centre, University of Oxford, Oxford, United Kingdom
raw_author_name: Claire Williams
raw_affiliation_strings: Health Economics Research Centre, University of Oxford, Oxford, United Kingdom
raw_author_name: Borislava Mihaylova
raw_affiliation_strings: Health Economics Research Centre, University of Oxford, Oxford, United Kingdom
EE350 Economic and Clinical Impact of Older Adult Vaccination With the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico
Year: 2025
Type: article
Language: en
Topic: Respiratory viral infections research
Authors and affiliations:
raw_author_name: Veronica Judith Guajardo
raw_affiliation_strings: Pfizer Mexico, Mexico City, Mexico
raw_author_name: Robyn Kendall
raw_affiliation_strings: Evidinno Outcomes Research Inc, Vancouver, BC, Canada
raw_author_name: Nishu Gaind
raw_affiliation_strings: Evidinno Outcomes Research Inc, Vancouver, BC, Canada
raw_author_name: Luka Ivkovic
raw_affiliation_strings: Evidinno Outcomes Research Inc, Vancouver, BC, Canada
raw_author_name: Rengina Kefalogianni
raw_affiliation_strings: Pfizer Ltd., Tadworth, United Kingdom
raw_author_name: Diana Mendes
raw_affiliation_strings: Pfizer Ltd., Tadworth, United Kingdom
EE222 Cost-Effectiveness and Budget Impact Analysis of Noninvasive Prenatal Testing (NIPT) for the Identification of Fetal Chromosomal Aneuploidies in Brazilian Private Healthcare System
Year: 2025
Type: article
Language: en
Topic: Prenatal Screening and Diagnostics
Authors and affiliations:
raw_author_name: Janaina Cardoso Marinho
raw_affiliation_strings: Núcleo de Avaliação de Tecnologias em Saúde da Unimed do Brasil (NATS UB), São Paulo, Brazil
raw_author_name: Junior Fadim
raw_affiliation_strings: Núcleo de Avaliação de Tecnologias em Saúde da Unimed do Brasil (NATS UB), São Paulo, Brazil
raw_author_name: Ricardo dos Santos Simões
raw_affiliation_strings: Núcleo de Avaliação de Tecnologias em Saúde da Unimed do Brasil (NATS UB), São Paulo, Brazil
raw_author_name: Julia Simoes Correa Galendi
raw_affiliation_strings: Associate Researcher, Núcleo de Avaliação de Tecnologias em Saúde da Unimed do Brasil (NATS UB), São Paulo, Brazil
MSR63 Cost-Effectiveness Modeling Based on a Clinical Trial Re-analysis Using Multimodal Machine Artificial Intelligence Methodology: Predicting Which Patients May Benefit Most From the Addition of Tremelimumab to Durvalumab Plus Chemotherapy in First-Line Metastatic Non-Small-Cell Lung Cancer
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Tristan Gonzalez
raw_affiliation_strings: AstraZeneca AG, Baar, Switzerland
raw_author_name: Amanda Remorino
raw_affiliation_strings: AstraZeneca, Barcelona, Spain
raw_author_name: Miguel Miranda
raw_affiliation_strings: AstraZeneca, Cambridge, United Kingdom
raw_author_name: Vivian Peirce
raw_affiliation_strings: AstraZeneca, Cambridge, United Kingdom
raw_author_name: David Heidenwag
raw_affiliation_strings: AstraZeneca, London, United Kingdom
raw_author_name: Colin Thierry
raw_affiliation_strings: Sophia Genetics, Bordeaux, France
raw_author_name: Rucha Vadia
raw_affiliation_strings: Health Economics and Payer Evidence, AstraZeneca BeLux, Brussels, Belgium
RWD168 Risk of Abdominal Hernia Repair in Patients With Intestinal Stoma in Italy: A Real-World Analysis
Year: 2025
Type: article
Language: en
Topic: Stoma care and complications
Authors and affiliations:
raw_author_name: Matteo Scortichini
raw_affiliation_strings: Economic Evaluation and HTA (EEHTA CEIS), Department of Economics and Finance, Faculty of Economics, Rome, Italy
raw_author_name: Paolo Sciattella
raw_affiliation_strings: Economic Evaluation and HTA (EEHTA CEIS), Department of Economics and Finance, Faculty of Economics, Rome, Italy
EE419 Estimating Health Utility Decrements Associated With Chronic Disease Outcomes Using MEPS
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Piaopiao Li
raw_affiliation_strings: PhD candidate, University of Florida, Gainesville, FL, USA
raw_author_name: Hui Shao
raw_affiliation_strings: Emory University, Atlanta, GA, USA
EPH50 Comparative Epidemiological Burden of Osteoarthritis in Eastern Central and Western Europe Based on the Global Burden of Disease Study 2021
Year: 2025
Type: article
Language: en
Topic: Osteoarthritis Treatment and Mechanisms
Authors and affiliations:
raw_author_name: Luca Fanni Kajos
raw_affiliation_strings: Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
raw_author_name: Bálint Molics
raw_affiliation_strings: Institute of Physiotherapy and Sport Science, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
raw_author_name: Dalma Pónusz-Kovács
raw_affiliation_strings: Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
raw_author_name: Bettina Kovács
raw_affiliation_strings: Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
raw_author_name: Imre Boncz
raw_affiliation_strings: Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
EE355 Economic Burden Associated With Type 2 Diabetes Mellitus in France: An Update From the National Insurance Claim Database
Year: 2025
Type: article
Language: en
Topic: Healthcare Systems and Practices
Authors and affiliations:
raw_author_name: Bruno Guerci
raw_affiliation_strings: CHRU Nancy, Brabois Hospital, University of Lorraine, Vandoeuvre-les-Nancy, France
raw_author_name: christele blanc-bisson
raw_affiliation_strings: Département de Médecine Générale, Bordeaux University, Bordeaux, France
raw_author_name: Eric Vicaut
raw_affiliation_strings: URC HUSLS, Lariboisière Fernand Vidal Hospital, Paris, France
raw_author_name: Gérard André De Pouvourville
raw_affiliation_strings: Departament of Economics, ESSEC Business School, Paris, France
raw_author_name: Bruno DETOURNAY
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
raw_author_name: Corinne Emery
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
raw_author_name: Isabelle Bureau
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
raw_author_name: Taos Ihaddadene-Salzgeber
raw_affiliation_strings: Abbott, Rungis, France
raw_author_name: Fleur Levrat Guillen
raw_affiliation_strings: Abbott Diabetes Care, Maidenhead, United Kingdom
raw_author_name: Jean-Pierre Riveline
raw_affiliation_strings: Lariboisière Hospital AP-HP, Paris, France
HPR87 Extension of the Mammographic Screening Program in Italy: Cost-Benefit Analysis and Impact of Early Diagnosis in the 45-74 Age Group
Year: 2025
Type: article
Language: en
Topic: Global Cancer Incidence and Screening
Authors and affiliations:
raw_author_name: Eugenio Di Brino
raw_affiliation_strings: Co-Founder & Partner, Altems Advisory, Università Cattolica del Sacro Cuore, Roma, Italy
raw_author_name: Michele Basile
raw_affiliation_strings: Altems Advisory, Università Cattolica del Sacro Cuore, Roma, Rome, Italy
raw_author_name: Filippo Rumi
raw_affiliation_strings: Altems Advisory, Università Cattolica del Sacro Cuore, Roma, Italy
HPR101 From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Andrea Bernardini
raw_affiliation_strings: Certara Evidence and Access, London, United Kingdom
raw_author_name: Katarzyna Lasota
raw_affiliation_strings: Certara Evidence and Access, Kraków, Poland
raw_author_name: Sanja Stanisic
raw_affiliation_strings: Certara Evidence and Access, Milan, Italy
MSR203 Traditional vs. Generative AI: A Rapid Systematic Review Assessing Accuracy and Efficiency of AI in Title/Abstract Screening
Year: 2025
Type: article
Language: en
Topic: Artificial Intelligence in Healthcare and Education
Authors and affiliations:
raw_author_name: Emily Hardy
raw_affiliation_strings: Petauri Evidence, Bicester, United Kingdom
raw_author_name: Amelia Peddle
raw_affiliation_strings: Petauri Evidence, Bicester, United Kingdom
raw_author_name: Judith Peatman
raw_affiliation_strings: Petauri Evidence, Bicester, United Kingdom
raw_author_name: Janine Ross
raw_affiliation_strings: Petauri Evidence, Bicester, United Kingdom
raw_author_name: Shona Lang
raw_affiliation_strings: Petauri Evidence, Bicester, United Kingdom
P28 Survival Time-Adjusted Indirect Comparisons: A New Methodology for Comparing Between Phases of Treatment in Early Cancer
Year: 2025
Type: article
Language: en
Topic: Bladder and Urothelial Cancer Treatments
Authors and affiliations:
raw_author_name: Robert Hettle
raw_affiliation_strings: Health Technology Assessment and Modelling Science, AstraZeneca, Cambridge, United Kingdom
raw_author_name: Jack Williams
raw_affiliation_strings: Health Technology Assessment and Modelling Science, AstraZeneca, Cambridge, United Kingdom
raw_author_name: Miranda Cooper
raw_affiliation_strings: Health Technology Assessment and Modelling Science, AstraZeneca, Barcelona, Spain
raw_author_name: Leana Bellanca
raw_affiliation_strings: Health Economics and Payer Evidence, AstraZeneca, Cambridge, United Kingdom